Latest filing published 26 Feb 2021 for Scopus BioPharma Inc., €1,168.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert J. Gibson: trading record in brief
This profile gathers the share dealings of Robert J. Gibson in Scopus BioPharma Inc. Between 24 February 2021 and 25 February 2021, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €2,313). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 26 February 2021: an open-market purchase of €1,168, in Scopus BioPharma Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert J. Gibson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150 shares@ US$9.46Common Stock, par value $0.001SEC:0001104659-21-028944:0Canonical exit: 25 May 2021 (T+90)
- 150 shares@ US$9.29Common Stock, par value $0.001SEC:0001104659-21-028944:1Canonical exit: 26 May 2021 (T+90)
2 of 2 declarations